Abstract
Summary
Supportive initiatives by the public and private sector for R&D with respect to various therapeutic areas, rising adoption of AI-based technologies among pharmaceutical companies and academia, and growing penetration of artificial intelligence (AI), are among the factors driving the market.
The global market for AI-based Clinical Trials Solution Provider was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for AI-based Clinical Trials Solution Provider was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for AI-based Clinical Trials Solution Provider was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for AI-based Clinical Trials Solution Provider was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of AI-based Clinical Trials Solution Provider include Unlearn.AI, Inc., Saama Technologies, Antidote Technologies, Inc., Phesi, Deep 6 AI, Innoplexus, Mendel.ai, Intelligencia and Median Technologies, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for AI-based Clinical Trials Solution Provider, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of AI-based Clinical Trials Solution Provider by region & country, by Type, and by Application.
The AI-based Clinical Trials Solution Provider market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI-based Clinical Trials Solution Provider.
Market Segmentation
By Company
Unlearn.AI, Inc.
Saama Technologies
Antidote Technologies, Inc.
Phesi
Deep 6 AI
Innoplexus
Mendel.ai
Intelligencia
Median Technologies
Symphony AI
BioAge Labs, Inc.
AiCure, LLC
CONSILX
DEEP LENS AI
Halo Health Systems
Pharmaseal
Ardigen
Trials.Ai
Koneksa Health
Euretos
BioSymetrics
Google- Verily
GNS Healthcare
IBM Watson
Exscientia
Segment by Type:
Phase-I
Phase-II
Phase-III
Segment by Application
Pharmaceutical Companies
Academia
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of AI-based Clinical Trials Solution Provider manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of AI-based Clinical Trials Solution Provider in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of AI-based Clinical Trials Solution Provider in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global market for AI-based Clinical Trials Solution Provider was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for AI-based Clinical Trials Solution Provider was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for AI-based Clinical Trials Solution Provider was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for AI-based Clinical Trials Solution Provider was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of AI-based Clinical Trials Solution Provider include Unlearn.AI, Inc., Saama Technologies, Antidote Technologies, Inc., Phesi, Deep 6 AI, Innoplexus, Mendel.ai, Intelligencia and Median Technologies, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for AI-based Clinical Trials Solution Provider, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of AI-based Clinical Trials Solution Provider by region & country, by Type, and by Application.
The AI-based Clinical Trials Solution Provider market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI-based Clinical Trials Solution Provider.
Market Segmentation
By Company
Unlearn.AI, Inc.
Saama Technologies
Antidote Technologies, Inc.
Phesi
Deep 6 AI
Innoplexus
Mendel.ai
Intelligencia
Median Technologies
Symphony AI
BioAge Labs, Inc.
AiCure, LLC
CONSILX
DEEP LENS AI
Halo Health Systems
Pharmaseal
Ardigen
Trials.Ai
Koneksa Health
Euretos
BioSymetrics
Google- Verily
GNS Healthcare
IBM Watson
Exscientia
Segment by Type:
Phase-I
Phase-II
Phase-III
Segment by Application
Pharmaceutical Companies
Academia
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of AI-based Clinical Trials Solution Provider manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of AI-based Clinical Trials Solution Provider in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of AI-based Clinical Trials Solution Provider in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 AI-based Clinical Trials Solution Provider Product Introduction
1.2 Global AI-based Clinical Trials Solution Provider Market Size Forecast
1.3 AI-based Clinical Trials Solution Provider Market Trends & Drivers
1.3.1 AI-based Clinical Trials Solution Provider Industry Trends
1.3.2 AI-based Clinical Trials Solution Provider Market Drivers & Opportunity
1.3.3 AI-based Clinical Trials Solution Provider Market Challenges
1.3.4 AI-based Clinical Trials Solution Provider Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global AI-based Clinical Trials Solution Provider Players Revenue Ranking (2023)
2.2 Global AI-based Clinical Trials Solution Provider Revenue by Company (2019-2024)
2.3 Key Companies AI-based Clinical Trials Solution Provider Manufacturing Base Distribution and Headquarters
2.4 Key Companies AI-based Clinical Trials Solution Provider Product Offered
2.5 Key Companies Time to Begin Mass Production of AI-based Clinical Trials Solution Provider
2.6 AI-based Clinical Trials Solution Provider Market Competitive Analysis
2.6.1 AI-based Clinical Trials Solution Provider Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by AI-based Clinical Trials Solution Provider Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI-based Clinical Trials Solution Provider as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Phase-I
3.1.2 Phase-II
3.1.3 Phase-III
3.2 Global AI-based Clinical Trials Solution Provider Sales Value by Type
3.2.1 Global AI-based Clinical Trials Solution Provider Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global AI-based Clinical Trials Solution Provider Sales Value, by Type (2019-2030)
3.2.3 Global AI-based Clinical Trials Solution Provider Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharmaceutical Companies
4.1.2 Academia
4.1.3 Others
4.2 Global AI-based Clinical Trials Solution Provider Sales Value by Application
4.2.1 Global AI-based Clinical Trials Solution Provider Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global AI-based Clinical Trials Solution Provider Sales Value, by Application (2019-2030)
4.2.3 Global AI-based Clinical Trials Solution Provider Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global AI-based Clinical Trials Solution Provider Sales Value by Region
5.1.1 Global AI-based Clinical Trials Solution Provider Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global AI-based Clinical Trials Solution Provider Sales Value by Region (2019-2024)
5.1.3 Global AI-based Clinical Trials Solution Provider Sales Value by Region (2025-2030)
5.1.4 Global AI-based Clinical Trials Solution Provider Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America AI-based Clinical Trials Solution Provider Sales Value, 2019-2030
5.2.2 North America AI-based Clinical Trials Solution Provider Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe AI-based Clinical Trials Solution Provider Sales Value, 2019-2030
5.3.2 Europe AI-based Clinical Trials Solution Provider Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific AI-based Clinical Trials Solution Provider Sales Value, 2019-2030
5.4.2 Asia Pacific AI-based Clinical Trials Solution Provider Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America AI-based Clinical Trials Solution Provider Sales Value, 2019-2030
5.5.2 South America AI-based Clinical Trials Solution Provider Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa AI-based Clinical Trials Solution Provider Sales Value, 2019-2030
5.6.2 Middle East & Africa AI-based Clinical Trials Solution Provider Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions AI-based Clinical Trials Solution Provider Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions AI-based Clinical Trials Solution Provider Sales Value
6.3 United States
6.3.1 United States AI-based Clinical Trials Solution Provider Sales Value, 2019-2030
6.3.2 United States AI-based Clinical Trials Solution Provider Sales Value by Type (%), 2023 VS 2030
6.3.3 United States AI-based Clinical Trials Solution Provider Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe AI-based Clinical Trials Solution Provider Sales Value, 2019-2030
6.4.2 Europe AI-based Clinical Trials Solution Provider Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe AI-based Clinical Trials Solution Provider Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China AI-based Clinical Trials Solution Provider Sales Value, 2019-2030
6.5.2 China AI-based Clinical Trials Solution Provider Sales Value by Type (%), 2023 VS 2030
6.5.3 China AI-based Clinical Trials Solution Provider Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan AI-based Clinical Trials Solution Provider Sales Value, 2019-2030
6.6.2 Japan AI-based Clinical Trials Solution Provider Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan AI-based Clinical Trials Solution Provider Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea AI-based Clinical Trials Solution Provider Sales Value, 2019-2030
6.7.2 South Korea AI-based Clinical Trials Solution Provider Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea AI-based Clinical Trials Solution Provider Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia AI-based Clinical Trials Solution Provider Sales Value, 2019-2030
6.8.2 Southeast Asia AI-based Clinical Trials Solution Provider Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia AI-based Clinical Trials Solution Provider Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India AI-based Clinical Trials Solution Provider Sales Value, 2019-2030
6.9.2 India AI-based Clinical Trials Solution Provider Sales Value by Type (%), 2023 VS 2030
6.9.3 India AI-based Clinical Trials Solution Provider Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Unlearn.AI, Inc.
7.1.1 Unlearn.AI, Inc. Profile
7.1.2 Unlearn.AI, Inc. Main Business
7.1.3 Unlearn.AI, Inc. AI-based Clinical Trials Solution Provider Products, Services and Solutions
7.1.4 Unlearn.AI, Inc. AI-based Clinical Trials Solution Provider Revenue (US$ Million) & (2019-2024)
7.1.5 Unlearn.AI, Inc. Recent Developments
7.2 Saama Technologies
7.2.1 Saama Technologies Profile
7.2.2 Saama Technologies Main Business
7.2.3 Saama Technologies AI-based Clinical Trials Solution Provider Products, Services and Solutions
7.2.4 Saama Technologies AI-based Clinical Trials Solution Provider Revenue (US$ Million) & (2019-2024)
7.2.5 Saama Technologies Recent Developments
7.3 Antidote Technologies, Inc.
7.3.1 Antidote Technologies, Inc. Profile
7.3.2 Antidote Technologies, Inc. Main Business
7.3.3 Antidote Technologies, Inc. AI-based Clinical Trials Solution Provider Products, Services and Solutions
7.3.4 Antidote Technologies, Inc. AI-based Clinical Trials Solution Provider Revenue (US$ Million) & (2019-2024)
7.3.5 Phesi Recent Developments
7.4 Phesi
7.4.1 Phesi Profile
7.4.2 Phesi Main Business
7.4.3 Phesi AI-based Clinical Trials Solution Provider Products, Services and Solutions
7.4.4 Phesi AI-based Clinical Trials Solution Provider Revenue (US$ Million) & (2019-2024)
7.4.5 Phesi Recent Developments
7.5 Deep 6 AI
7.5.1 Deep 6 AI Profile
7.5.2 Deep 6 AI Main Business
7.5.3 Deep 6 AI AI-based Clinical Trials Solution Provider Products, Services and Solutions
7.5.4 Deep 6 AI AI-based Clinical Trials Solution Provider Revenue (US$ Million) & (2019-2024)
7.5.5 Deep 6 AI Recent Developments
7.6 Innoplexus
7.6.1 Innoplexus Profile
7.6.2 Innoplexus Main Business
7.6.3 Innoplexus AI-based Clinical Trials Solution Provider Products, Services and Solutions
7.6.4 Innoplexus AI-based Clinical Trials Solution Provider Revenue (US$ Million) & (2019-2024)
7.6.5 Innoplexus Recent Developments
7.7 Mendel.ai
7.7.1 Mendel.ai Profile
7.7.2 Mendel.ai Main Business
7.7.3 Mendel.ai AI-based Clinical Trials Solution Provider Products, Services and Solutions
7.7.4 Mendel.ai AI-based Clinical Trials Solution Provider Revenue (US$ Million) & (2019-2024)
7.7.5 Mendel.ai Recent Developments
7.8 Intelligencia
7.8.1 Intelligencia Profile
7.8.2 Intelligencia Main Business
7.8.3 Intelligencia AI-based Clinical Trials Solution Provider Products, Services and Solutions
7.8.4 Intelligencia AI-based Clinical Trials Solution Provider Revenue (US$ Million) & (2019-2024)
7.8.5 Intelligencia Recent Developments
7.9 Median Technologies
7.9.1 Median Technologies Profile
7.9.2 Median Technologies Main Business
7.9.3 Median Technologies AI-based Clinical Trials Solution Provider Products, Services and Solutions
7.9.4 Median Technologies AI-based Clinical Trials Solution Provider Revenue (US$ Million) & (2019-2024)
7.9.5 Median Technologies Recent Developments
7.10 Symphony AI
7.10.1 Symphony AI Profile
7.10.2 Symphony AI Main Business
7.10.3 Symphony AI AI-based Clinical Trials Solution Provider Products, Services and Solutions
7.10.4 Symphony AI AI-based Clinical Trials Solution Provider Revenue (US$ Million) & (2019-2024)
7.10.5 Symphony AI Recent Developments
7.11 BioAge Labs, Inc.
7.11.1 BioAge Labs, Inc. Profile
7.11.2 BioAge Labs, Inc. Main Business
7.11.3 BioAge Labs, Inc. AI-based Clinical Trials Solution Provider Products, Services and Solutions
7.11.4 BioAge Labs, Inc. AI-based Clinical Trials Solution Provider Revenue (US$ Million) & (2019-2024)
7.11.5 BioAge Labs, Inc. Recent Developments
7.12 AiCure, LLC
7.12.1 AiCure, LLC Profile
7.12.2 AiCure, LLC Main Business
7.12.3 AiCure, LLC AI-based Clinical Trials Solution Provider Products, Services and Solutions
7.12.4 AiCure, LLC AI-based Clinical Trials Solution Provider Revenue (US$ Million) & (2019-2024)
7.12.5 AiCure, LLC Recent Developments
7.13 CONSILX
7.13.1 CONSILX Profile
7.13.2 CONSILX Main Business
7.13.3 CONSILX AI-based Clinical Trials Solution Provider Products, Services and Solutions
7.13.4 CONSILX AI-based Clinical Trials Solution Provider Revenue (US$ Million) & (2019-2024)
7.13.5 CONSILX Recent Developments
7.14 DEEP LENS AI
7.14.1 DEEP LENS AI Profile
7.14.2 DEEP LENS AI Main Business
7.14.3 DEEP LENS AI AI-based Clinical Trials Solution Provider Products, Services and Solutions
7.14.4 DEEP LENS AI AI-based Clinical Trials Solution Provider Revenue (US$ Million) & (2019-2024)
7.14.5 DEEP LENS AI Recent Developments
7.15 Halo Health Systems
7.15.1 Halo Health Systems Profile
7.15.2 Halo Health Systems Main Business
7.15.3 Halo Health Systems AI-based Clinical Trials Solution Provider Products, Services and Solutions
7.15.4 Halo Health Systems AI-based Clinical Trials Solution Provider Revenue (US$ Million) & (2019-2024)
7.15.5 Halo Health Systems Recent Developments
7.16 Pharmaseal
7.16.1 Pharmaseal Profile
7.16.2 Pharmaseal Main Business
7.16.3 Pharmaseal AI-based Clinical Trials Solution Provider Products, Services and Solutions
7.16.4 Pharmaseal AI-based Clinical Trials Solution Provider Revenue (US$ Million) & (2019-2024)
7.16.5 Pharmaseal Recent Developments
7.17 Ardigen
7.17.1 Ardigen Profile
7.17.2 Ardigen Main Business
7.17.3 Ardigen AI-based Clinical Trials Solution Provider Products, Services and Solutions
7.17.4 Ardigen AI-based Clinical Trials Solution Provider Revenue (US$ Million) & (2019-2024)
7.17.5 Ardigen Recent Developments
7.18 Trials.Ai
7.18.1 Trials.Ai Profile
7.18.2 Trials.Ai Main Business
7.18.3 Trials.Ai AI-based Clinical Trials Solution Provider Products, Services and Solutions
7.18.4 Trials.Ai AI-based Clinical Trials Solution Provider Revenue (US$ Million) & (2019-2024)
7.18.5 Trials.Ai Recent Developments
7.19 Koneksa Health
7.19.1 Koneksa Health Profile
7.19.2 Koneksa Health Main Business
7.19.3 Koneksa Health AI-based Clinical Trials Solution Provider Products, Services and Solutions
7.19.4 Koneksa Health AI-based Clinical Trials Solution Provider Revenue (US$ Million) & (2019-2024)
7.19.5 Koneksa Health Recent Developments
7.20 Euretos
7.20.1 Euretos Profile
7.20.2 Euretos Main Business
7.20.3 Euretos AI-based Clinical Trials Solution Provider Products, Services and Solutions
7.20.4 Euretos AI-based Clinical Trials Solution Provider Revenue (US$ Million) & (2019-2024)
7.20.5 Euretos Recent Developments
7.21 BioSymetrics
7.21.1 BioSymetrics Profile
7.21.2 BioSymetrics Main Business
7.21.3 BioSymetrics AI-based Clinical Trials Solution Provider Products, Services and Solutions
7.21.4 BioSymetrics AI-based Clinical Trials Solution Provider Revenue (US$ Million) & (2019-2024)
7.21.5 BioSymetrics Recent Developments
7.22 Google- Verily
7.22.1 Google- Verily Profile
7.22.2 Google- Verily Main Business
7.22.3 Google- Verily AI-based Clinical Trials Solution Provider Products, Services and Solutions
7.22.4 Google- Verily AI-based Clinical Trials Solution Provider Revenue (US$ Million) & (2019-2024)
7.22.5 Google- Verily Recent Developments
7.23 GNS Healthcare
7.23.1 GNS Healthcare Profile
7.23.2 GNS Healthcare Main Business
7.23.3 GNS Healthcare AI-based Clinical Trials Solution Provider Products, Services and Solutions
7.23.4 GNS Healthcare AI-based Clinical Trials Solution Provider Revenue (US$ Million) & (2019-2024)
7.23.5 GNS Healthcare Recent Developments
7.24 IBM Watson
7.24.1 IBM Watson Profile
7.24.2 IBM Watson Main Business
7.24.3 IBM Watson AI-based Clinical Trials Solution Provider Products, Services and Solutions
7.24.4 IBM Watson AI-based Clinical Trials Solution Provider Revenue (US$ Million) & (2019-2024)
7.24.5 IBM Watson Recent Developments
7.25 Exscientia
7.25.1 Exscientia Profile
7.25.2 Exscientia Main Business
7.25.3 Exscientia AI-based Clinical Trials Solution Provider Products, Services and Solutions
7.25.4 Exscientia AI-based Clinical Trials Solution Provider Revenue (US$ Million) & (2019-2024)
7.25.5 Exscientia Recent Developments
8 Industry Chain Analysis
8.1 AI-based Clinical Trials Solution Provider Industrial Chain
8.2 AI-based Clinical Trials Solution Provider Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 AI-based Clinical Trials Solution Provider Sales Model
8.5.2 Sales Channel
8.5.3 AI-based Clinical Trials Solution Provider Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer